Scarica l'app Stockscreener
6.65
0.76%
0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.60
Aprire:
$6.72
Volume 24 ore:
55,897
Relative Volume:
0.57
Capitalizzazione di mercato:
$182.42M
Reddito:
$21.25M
Utile/perdita netta:
$-16.05M
Rapporto P/E:
-10.90
EPS:
-0.61
Flusso di cassa netto:
$-17.14M
1 W Prestazione:
-0.45%
1M Prestazione:
+15.85%
6M Prestazione:
+18.12%
1 anno Prestazione:
-25.11%
Intervallo 1D:
$6.65
$6.79
Intervallo di 1 settimana:
$6.57
$6.87
Portata 52W:
$3.96
$11.49
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
Nome
Fennec Pharmaceuticals Inc
Settore
Industria
Telefono
(919) 636-4530
Indirizzo
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Confronta FENC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
6.65 | 182.42M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-22 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | Iniziato | CapitalOne | Overweight |
| 2022-08-08 | Ripresa | Craig Hallum | Buy |
| 2020-06-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-10-11 | Iniziato | Goldman | Buy |
Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie
Chris Anigeron Rallis Sells 1,186 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat
(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Above 50-Day Moving AverageHere's Why - MarketBeat
Fennec Pharmaceuticals director sells shares worth $8,088 By Investing.com - Investing.com Nigeria
Fennec Pharmaceuticals director sells shares worth $8,088 - Investing.com India
(FENC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells 10,000 Shares of Stock - MarketBeat
Rostislav Christov Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat
Fennec Pharmaceuticals Inc. - MENAFN.COM
Norgine introduces PEDMARQSI in Germany for pediatric cancer care - MSN
Stocks In Play: Fennec Pharmaceuticals Inc. By Baystreet.ca - Investing.com Canada
Fennec Pharmaceuticals director Raykov sells $66,600 in shares - MSN
Fennec Pharmaceuticals Announces Commercial Launch of Pedmarqsi in Germany - Marketscreener.com
Fennec Pharmaceuticals' Pedmarqsi Launched in Germany by Norgine Pharmaceuticals - Marketscreener.com
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany - The Manila Times
Fennec Pharmaceuticals Brief: Announcing Commercial Launch of PEDMARQSI In Germany - Marketscreener.com
Revolutionary Cancer Drug PEDMARQSI Now Available in Germany$273M Deal Potential - StockTitan
Insider Sell Alert: Rosty Raykov Sells 10,000 Shares of Fennec P - GuruFocus.com
Fennec Pharmaceuticals director Raykov sells $66,600 in shares By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Sees Large Decrease in Short Interest - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Above 50-Day Moving AverageHere's What Happened - MarketBeat
Trend Tracker for (FENC) - Stock Traders Daily
Fennec PharmaA Sound Investment? - RTTNews
Fennec Pharmaceuticals (NASDAQ:FENC) shareholder returns have been respectable, earning 41% in 3 years - Simply Wall St
Fennec Pharmaceuticals (NASDAQ:FENC) versus CARGO Therapeutics (NASDAQ:CRGX) Financial Survey - Defense World
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Barclays PLC Raises Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Learn to Evaluate (FENC) using the Charts - Stock Traders Daily
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$87,552.00 in Stock - MarketBeat
Barclays PLC Grows Position in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock - MarketBeat
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares By Investing.com - Investing.com Australia
Fennec Pharmaceuticals director Raykov Rosty sells $60,800 in shares - Investing.com
Franklin Resources Inc. Has $74,000 Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
State Street Corp Has $1.64 Million Stake in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Above 50 Day Moving AverageShould You Sell? - MarketBeat
Stocks In Play: Fennec Pharmaceuticals Inc. - Barchart
(FENC) Trading Advice - Stock Traders Daily
Fennec Pharmaceuticals Inc Azioni (FENC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Fennec Pharmaceuticals Inc Azioni (FENC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| RALLIS CHRIS A | Director |
Feb 14 '25 |
Sale |
6.82 |
1,186 |
8,089 |
53,020 |
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):